novavax covid news - Search News

Order byBest matchMost fresh

Novavax, COVID-19 and FDA

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, Nuvaxovid, is designed for older adults and those between the ages of 12 and 64 who have underlying conditions that puts them at higher risk from the disease.

· 5d · on MSN

WebMD · 4d

FDA Approves Novavax COVID Vaccine With Restricted Use

· 6d · on MSN

FDA approves Novavax's COVID-19 vaccine with limitations

FDA ends routine COVID shots for healthy young Americans

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated COVID-19 vaccines will now require randomized, controlled trials for approval in...

Arizona PBS · 1d

Alaska Dispatch News · 1d

Opinion: The FDA’s new covid vaccine policy is clear as mud

STAT · 1d

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

7don MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness.

F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

STAT6d

Novavax wins narrowed approval for its Covid-19 shot after delay

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

BioPharma Dive5d

Novavax’s COVID vaccine gets FDA approval, but with limits

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the company.

5don MSN

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.